Product Information

METHOTREXATE 50 MG/2 ML VIAL is a generic product labeled by Accord Healthcare Inc., priced at $1.7390 per ML under NDC 16729027730. Its NADAC has been published 634 times since May 7, 2014.

METHOTREXATE 50 MG/2 ML VIAL

Methotrexate
$1.7390per ML

Strength

25 mg/mL

NDC

16729027730

Classification

Generic

Dosage Form

INJECTION

Route

INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS

Last Updated

6/17/2026

Active Ingredients

METHOTREXATE

Approval Type

Generic (ANDA)

FDA Application

ANDA040716

On Market Since

3/7/2014

Pharmacological Classes

Folate Analog Metabolic Inhibitor
Folic Acid Metabolism Inhibitors

Price Statistics

The NADAC for METHOTREXATE 50 MG/2 ML VIAL has been published 634 times since May 7, 2014, and over the history we have for it it has declined 11.0%. The table below summarizes its recorded NADAC range and movement.

Current price$1.7390 per ML
All-time high$3.1936 (Mar 11, 2020)
All-time low$1.2092 (Aug 23, 2017)
52-week high$2.4419
52-week low$1.5600
Median price$1.6538
Average price$1.8590
Largest weekly change+53.6% (Jan 23, 2019)
Weeks tracked634
Tracking sinceMay 7, 2014

Price History

1W

0.0%

1M

-2.1%

3M

+0.1%

6M

+11.5%

1Y

-28.8%

3Y

-10.0%

5Y

+25.7%

All

-11.0%

Generic Alternatives

The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 63% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of METHOTREXATE 50 MG/2 ML VIAL?

The current National Average Drug Acquisition Cost (NADAC) for METHOTREXATE 50 MG/2 ML VIAL, manufactured by Accord Healthcare Inc., is $1.7390 per ML (NDC 16729027730), effective Jun 24, 2026.

How has the price of METHOTREXATE 50 MG/2 ML VIAL changed over time?

Over the history we have for it, the NADAC for METHOTREXATE 50 MG/2 ML VIAL has declined 11.0%. It has been tracked across 634 weekly CMS publications since May 7, 2014.

What are the highest and lowest recorded NADAC prices for METHOTREXATE 50 MG/2 ML VIAL?

Since May 7, 2014, the NADAC for METHOTREXATE 50 MG/2 ML VIAL has ranged from a low of $1.2092 (Aug 23, 2017) to a high of $3.1936 (Mar 11, 2020), with a median of $1.6538 per ML.

Are there cheaper alternatives to METHOTREXATE 50 MG/2 ML VIAL?

Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, METHOTREXATE 1 GRAM/40 ML VIAL, is $0.6450 per ML — about 63% below METHOTREXATE 50 MG/2 ML VIAL.

Who manufactures METHOTREXATE 50 MG/2 ML VIAL?

METHOTREXATE 50 MG/2 ML VIAL (NDC 16729027730) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.